Literature DB >> 1668801

Removal of the 2.2.2 cryptand (Kryptofix 2.2.2) from 18FDG by cation exchange.

D L Alexoff1, J S Fowler, S J Gatley.   

Abstract

The 2.2.2 cryptand [4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo-(8.8.8)-hexacosane] was trapped efficiently on Dowex AG50W-X8 (100-200 mesh) cation exchange resin. The concentration of the 2.2.2 cryptand in water with 0.1-2% methanol, or in 1 N HCl, was decreased by a factor of > 4000 using 1 mL (1.7 mequiv.) of AG50W-X8 and a flow rate of approx. 2 mL/min. K+, Cs+, Ag+ and Ba2+ forms were about equal in their ability to remove the 2.2.2 cryptand. A disposable cartridge containing 1 mL of hydrogen form resin was inserted into our automated 18FDG system so that the hydrolysate (in 2 cm3 of 1 N HCl) would pass through the cartridge before final purification. No cryptand was detected in the final product as determined by TLC with idoplantinate visualization. The detection limit was 2.5 micrograms/mL. Less than 3% of the total starting radioactivity was retained by the cation column. Quality assurance tests including apyrogenicity, sterility, radiochemical purity, carbohydrate composition and pH were not compromised by the incorporation of the cryptand removal cartridge.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668801     DOI: 10.1016/0883-2889(91)90195-7

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum A        ISSN: 0883-2889


  3 in total

1.  Radiofluorination of diaryliodonium tosylates under aqueous-organic and cryptand-free conditions.

Authors:  Joong-Hyun Chun; Sanjay Telu; Shuiyu Lu; Victor W Pike
Journal:  Org Biomol Chem       Date:  2013-06-26       Impact factor: 3.876

2.  Nucleophile assisting leaving groups: a strategy for aliphatic 18F-fluorination.

Authors:  Shuiyu Lu; Salvatore D Lepore; Song Ye Li; Deboprosad Mondal; Pamela C Cohn; Anjan K Bhunia; Victor W Pike
Journal:  J Org Chem       Date:  2009-08-07       Impact factor: 4.354

3.  Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals.

Authors:  Matthias Kuntzsch; Denis Lamparter; Nils Brüggener; Marco Müller; Gabriele J Kienzle; Gerald Reischl
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.